
Burzynski Research Institute Inc bases its business in Texas. Its shares trade under the stock symbols BZYR.PK and BZYR.OB on the Pink Sheets and the OTCBB, respectively. Investors should fully understand the risks of trading Pink Sheet stocks when making a decision to invest in these companies. Due to the fact that the company is listed on two exchanges, the shares may be slightly more marketable.
They are a very very small company with only 3 employees. The company's business plans might be adversely affected due to lack of employees. You should consider the risks related to a workforce of this size, when you evaluate this stock.
The company's share price reached $0.06 on Jan 6, 2009 The share price is currently 53.85 % lower than its 52 week high of $0.13. The low share price may indicate possible ongoing problems associated with the company's financial position. Share price movement over the last 52 weeks shows no real signs of a clear pattern forming. This stock appears to be trading at pretty low volumes, making it less attractive to traders, as the price could be highly volatile.
The company has recently announced news. Burzynski Research Institute Inc issued the following news " U.S. FDA Grants Orphan Drug Designation for Burzynski Research Institute¿s Antineoplaston Treatment for Gliomas " on Dec 02, 2008. Although this news is out there, it is too early to determine the ultimate effect that it will have on the company's share price.
| Symbol: | BZYR.PK |
| Type: | Pink Sheets/OTCBB |
| Company SIC: | N/A |
| Average volume: | N/A |
| Employees: | 3 |
| Phone: | 713-335-5697 |
| Fax: | 713-335-5699 |
| Website: | www.burzynskiclinic.com |
| Address: | TX Houston |
| Bussines address: | 9432 Old Katy Road Suite 200 Houston, TX 77055 United States |
| Mailing address: | N/A |